These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28911924)

  • 1. Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases.
    Lima L; Neves M; Oliveira MI; Dieguez L; Freitas R; Azevedo R; Gaiteiro C; Soares J; Ferreira D; Peixoto A; Fernandes E; Montezuma D; Tavares A; Ribeiro R; Castro A; Oliveira M; Fraga A; Reis CA; Santos LL; Ferreira JA
    Urol Oncol; 2017 Dec; 35(12):675.e1-675.e8. PubMed ID: 28911924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications.
    Neves M; Azevedo R; Lima L; Oliveira MI; Peixoto A; Ferreira D; Soares J; Fernandes E; Gaiteiro C; Palmeira C; Cotton S; Mereiter S; Campos D; Afonso LP; Ribeiro R; Fraga A; Tavares A; Mansinho H; Monteiro E; Videira PA; Freitas PP; Reis CA; Santos LL; Dieguez L; Ferreira JA
    N Biotechnol; 2019 Mar; 49():77-87. PubMed ID: 30273682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.
    Costa C; Pereira S; Lima L; Peixoto A; Fernandes E; Neves D; Neves M; Gaiteiro C; Tavares A; Gil da Costa RM; Cruz R; Amaro T; Oliveira PA; Ferreira JA; Santos LL
    PLoS One; 2015; 10(11):e0141253. PubMed ID: 26569621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target Score-A Proteomics Data Selection Tool Applied to Esophageal Cancer Identifies GLUT1-Sialyl Tn Glycoforms as Biomarkers of Cancer Aggressiveness.
    Cotton S; Ferreira D; Soares J; Peixoto A; Relvas-Santos M; Azevedo R; Piairo P; Diéguez L; Palmeira C; Lima L; Silva AMN; Lara Santos L; Ferreira JA
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours.
    Ferreira JA; Videira PA; Lima L; Pereira S; Silva M; Carrascal M; Severino PF; Fernandes E; Almeida A; Costa C; Vitorino R; Amaro T; Oliveira MJ; Reis CA; Dall'Olio F; Amado F; Santos LL
    Mol Oncol; 2013 Jun; 7(3):719-31. PubMed ID: 23567325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension.
    Peixoto A; Fernandes E; Gaiteiro C; Lima L; Azevedo R; Soares J; Cotton S; Parreira B; Neves M; Amaro T; Tavares A; Teixeira F; Palmeira C; Rangel M; Silva AM; Reis CA; Santos LL; Oliveira MJ; Ferreira JA
    Oncotarget; 2016 Sep; 7(39):63138-63157. PubMed ID: 27542232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours.
    Cotton S; Azevedo R; Gaiteiro C; Ferreira D; Lima L; Peixoto A; Fernandes E; Neves M; Neves D; Amaro T; Cruz R; Tavares A; Rangel M; Silva AMN; Santos LL; Ferreira JA
    Mol Oncol; 2017 Aug; 11(8):895-912. PubMed ID: 28156048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of
    Ecke TH; Kiani A; Schlomm T; Friedersdorff F; Rabien A; Jung K; Kilic E; Boström P; Tervahartiala M; Taimen P; Gleichenhagen J; Johnen G; Brüning T; Koch S; Roggisch J; Wirtz RM
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-derived sialyl-Tn-positive invasive bladder cancer xenografts in nude mice: an exploratory model study.
    Bernardo C; Costa C; Amaro T; Gonçalves M; Lopes P; Freitas R; Gärtner F; Amado F; Ferreira JA; Santos L
    Anticancer Res; 2014 Feb; 34(2):735-44. PubMed ID: 24511007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of carbohydrate antigens in advanced-stage ovarian carcinomas and their metastases-A clinicopathologic study.
    Davidson B; Gotlieb WH; Ben-Baruch G; Kopolovic J; Goldberg I; Nesland JM; Berner A; Bjåmer A; Bryne M
    Gynecol Oncol; 2000 Apr; 77(1):35-43. PubMed ID: 10739688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy.
    Lima L; Severino PF; Silva M; Miranda A; Tavares A; Pereira S; Fernandes E; Cruz R; Amaro T; Reis CA; Dall'Olio F; Amado F; Videira PA; Santos L; Ferreira JA
    Br J Cancer; 2013 Oct; 109(8):2106-14. PubMed ID: 24064971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple-marker immunohistochemical assessment of muscle-invasive bladder cancer: Is there prognostic significance?
    Labban M; Najdi J; Mukherji D; Abou-Kheir W; Tabbarah A; El-Hajj A
    Cancer Rep (Hoboken); 2021 Apr; 4(2):e1313. PubMed ID: 33538412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cells in patients with advanced urothelial carcinoma of the bladder: Association with tumor stage, lymph node metastases, FDG-PET findings, and survival.
    Abrahamsson J; Aaltonen K; Engilbertsson H; Liedberg F; Patschan O; Rydén L; Sjödahl G; Gudjonsson S
    Urol Oncol; 2017 Oct; 35(10):606.e9-606.e16. PubMed ID: 28676151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
    Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
    J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells.
    Carrascal MA; Severino PF; Guadalupe Cabral M; Silva M; Ferreira JA; Calais F; Quinto H; Pen C; Ligeiro D; Santos LL; Dall'Olio F; Videira PA
    Mol Oncol; 2014 May; 8(3):753-65. PubMed ID: 24656965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting outcomes in non-muscle invasive (Ta/T1) bladder cancer: the role of molecular grade based on luminal/basal phenotype.
    Rebola J; Aguiar P; Blanca A; Montironi R; Cimadamore A; Cheng L; Henriques V; Lobato-Faria P; Lopez-Beltran A
    Virchows Arch; 2019 Oct; 475(4):445-455. PubMed ID: 31240474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcripts of circulating tumor cells detected by a breast cancer-specific platform correlate with clinical stage in bladder cancer patients.
    Todenhöfer T; Hennenlotter J; Dorner N; Kühs U; Aufderklamm S; Rausch S; Bier S; Mischinger J; Schellbach D; Hauch S; Feniuk N; Bedke J; Gakis G; Stenzl A; Schwentner C
    J Cancer Res Clin Oncol; 2016 May; 142(5):1013-20. PubMed ID: 26910601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.
    Guo CC; Dadhania V; Zhang L; Majewski T; Bondaruk J; Sykulski M; Wronowska W; Gambin A; Wang Y; Zhang S; Fuentes-Mattei E; Kamat AM; Dinney C; Siefker-Radtke A; Choi W; Baggerly KA; McConkey D; Weinstein JN; Czerniak B
    Eur Urol; 2016 Oct; 70(4):611-620. PubMed ID: 26988609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC).
    Nicolazzo C; Busetto GM; Del Giudice F; Sperduti I; Giannarelli D; Gradilone A; Gazzaniga P; de Berardinis E; Raimondi C
    J Cancer Res Clin Oncol; 2017 Oct; 143(10):1971-1976. PubMed ID: 28555356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialosyl Tn antigen expression is associated with the prognosis of patients with advanced gastric cancer.
    Yamada T; Watanabe A; Yamada Y; Shino Y; Tanase M; Yamashita J; Miwa T; Nakano H
    Cancer; 1995 Nov; 76(9):1529-36. PubMed ID: 8635053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.